Innovative FO-SPR Label-free Strategy for Detecting Anti-RBD Antibodies in COVID-19 Patient Serum and Whole Blood-Reference-Cited by-同舟云学术

Innovative FO-SPR Label-free Strategy for Detecting Anti-RBD Antibodies in COVID-19 Patient Serum and Whole Blood

Author:

Qu Jia-Huan¹,Leirs Karen¹,Maes Wim²,Imbrechts Maya²,Callewaert Nico³,Lagrou Katrien⁴⁵,Geukens Nick²,Lammertyn Jeroen¹^ORCID,Spasic Dragana¹

Affiliation:

1. Department of Biosystems, Biosensors Group, KU Leuven, Willem de Croylaan 42, 3001 Leuven, Belgium

2. PharmAbs, KU Leuven, Herestraat 49, Box 820, 3000 Leuven, Belgium

3. AZ Groeninge Hospital, 8500 Kortrijk, Belgium

4. Department of Microbiology, Immunology and Transplantation, Laboratory of Clinical Bacteriology and Mycology, KU Leuven, 3000 Leuven, Belgium

5. Department of Laboratory Medicine and National Reference Centre for Respiratory Pathogens, University Hospitals Leuven, 3000 Leuven, Belgium

Funder

KU Leuven

Fonds Wetenschappelijk Onderzoek

Publisher

American Chemical Society (ACS)

Subject

Fluid Flow and Transfer Processes,Process Chemistry and Technology,Instrumentation,Bioengineering

Link

Reference53 articles.

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献